185 related articles for article (PubMed ID: 21543824)
1. Aging and osteoporosis in breast and prostate cancer.
VanderWalde A; Hurria A
CA Cancer J Clin; 2011; 61(3):139-56. PubMed ID: 21543824
[TBL] [Abstract][Full Text] [Related]
2. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
3. Androgen deprivation in veterans with prostate cancer: implications for skeletal health.
Wilcox A; Carnes ML; Moon TD; Tobias R; Baade H; Stamos E; Elliott ME
Ann Pharmacother; 2006 Dec; 40(12):2107-14. PubMed ID: 17132807
[TBL] [Abstract][Full Text] [Related]
4. Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer.
Swenson KK; Henly SJ; Shapiro AC; Schroeder LM
Clin J Oncol Nurs; 2005 Apr; 9(2):177-84. PubMed ID: 15853161
[TBL] [Abstract][Full Text] [Related]
5. Screening, prevention, detection, and treatment of cancer therapy-induced bone loss in patients with breast cancer.
Limburg CE
Oncol Nurs Forum; 2007 Jan; 34(1):55-63. PubMed ID: 17562633
[TBL] [Abstract][Full Text] [Related]
6. Cancer treatment-induced bone loss.
Adler RA
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):442-5. PubMed ID: 17982349
[TBL] [Abstract][Full Text] [Related]
7. Cancer treatment-induced bone loss in breast and prostate cancer.
Saad F; Adachi JD; Brown JP; Canning LA; Gelmon KA; Josse RG; Pritchard KI
J Clin Oncol; 2008 Nov; 26(33):5465-76. PubMed ID: 18955443
[TBL] [Abstract][Full Text] [Related]
8. Adverse bone effects during pharmacological breast cancer therapy.
Bjarnason NH; Hitz M; Jorgensen NR; Vestergaard P
Acta Oncol; 2008; 47(4):747-54. PubMed ID: 18465344
[TBL] [Abstract][Full Text] [Related]
9. Early breast and prostate cancer and clinical outcomes (fracture).
Chlebowski RT; Tagawa T
Oncology (Williston Park); 2009 Dec; 23(14 Suppl 5):16-20. PubMed ID: 20128324
[TBL] [Abstract][Full Text] [Related]
10. Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma.
Brown JE; Ellis SP; Silcocks P; Blumsohn A; Gutcher SA; Radstone C; Hancock BW; Hatton MQ; Coleman RE
Clin Cancer Res; 2006 Nov; 12(21):6480-6. PubMed ID: 17085662
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer.
Ross RW; Small EJ
J Urol; 2002 May; 167(5):1952-6. PubMed ID: 11956415
[TBL] [Abstract][Full Text] [Related]
12. Fracture risk in Danish men with prostate cancer: a nationwide register study.
Abrahamsen B; Nielsen MF; Eskildsen P; Andersen JT; Walter S; Brixen K
BJU Int; 2007 Oct; 100(4):749-54. PubMed ID: 17822455
[TBL] [Abstract][Full Text] [Related]
13. The role of bisphosphonates in men with prostate cancer receiving androgen deprivation therapy.
Smith MR
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):21-5. PubMed ID: 15202584
[TBL] [Abstract][Full Text] [Related]
14. Prevention of osteoporosis after breast cancer.
Reid DM
Maturitas; 2009 Sep; 64(1):4-8. PubMed ID: 19709826
[TBL] [Abstract][Full Text] [Related]
15. Hormone- and chemotherapy-induced bone loss in breast cancer.
Coleman RE
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):16-20. PubMed ID: 15202583
[TBL] [Abstract][Full Text] [Related]
16. Therapy Insight: osteoporosis during hormone therapy for prostate cancer.
Smith MR
Nat Clin Pract Urol; 2005 Dec; 2(12):608-15; quiz 628. PubMed ID: 16474548
[TBL] [Abstract][Full Text] [Related]
17. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
[TBL] [Abstract][Full Text] [Related]
18. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
Brufsky AM
Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for low trauma fractures in men with prostate cancer.
Ahlborg HG; Nguyen ND; Center JR; Eisman JA; Nguyen TV
Bone; 2008 Sep; 43(3):556-60. PubMed ID: 18585119
[TBL] [Abstract][Full Text] [Related]
20. Effects of third-generation aromatase inhibitors on bone.
McCloskey E
Eur J Cancer; 2006 May; 42(8):1044-51. PubMed ID: 16554149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
